Clinical Study | Open Access
Arben Ndreu, Dhimitër Kraja, Silva Bino, Artan Simaku, Iris Hatibi, Najada Çomo, Arjan Harxhi, Ilir Ohri, Kastriot Shytaj, Entela Kolovani, Hektor Sula, Arben Pilaca, Shane Morrison, Vania Rashidi, Ervin Çerçiz Mingomataj, "Clinical Findings in Albanian Patients with 2009 Influenza AH1N1 Admitted at the Intensive Care Unit", International Scholarly Research Notices, vol. 2013, Article ID 914840, 6 pages, 2013. https://doi.org/10.1155/2013/914840
Clinical Findings in Albanian Patients with 2009 Influenza AH1N1 Admitted at the Intensive Care Unit
Due to the ease of cross-continent spread of infectious diseases, the 2009 influenza AH1N1 (H1N1) affected many countries. This observational prospective study looked at Albanian patients admitted with 2009 H1N1 at the ICU of the Department of Infectious Diseases at the University Hospital Center of Tirana, from November 2009 to March 2010. Demographic data, symptoms, comorbidities, and clinical outcomes were collected from each patient. The number of days spent in the ICU was recorded for each patient along with their radiological and laboratory findings, and outcome at discharge. Critical illness occurred in 31 patients admitted with confirmed 2009 H1N1. The median age of patients was 35 years. Five (16.1%) patients required endotracheal intubation; noninvasive oxygen therapy (NIV) was used in 15 (48.4%) patients via nasal tube; and continuous positive airway pressure (CPAP) and pressure support ventilation (PSV) oxygen masks were used in 11 (35.5%) patients. All patients were treated with oseltamivir. Four patients admitted and treated did not survive. Critical illness in the setting of 2009 H1N1 admitted in the ICU predominantly affected young adults. NIV could play a role in treating 2009 influenza H1N1 infection-related hypoxemic respiratory failure that was associated with severe hypoxemia, pneumonia, requirement for prolonged mechanical ventilation, and the frequent use of antiviral therapy.
In April 2009, a new strain of human H1N1 influenza A virus (H1N1) was identified in the US [1, 2]. The number of H1N1-related cases worldwide showing symptoms ranging from fever and cough to diarrhea and vomiting was in the thousands [3, 4]. Along with the aforementioned symptoms, the influenza H1N1 virus has been associated with acute respiratory distress syndrome and pneumonia [5, 6].
The first laboratory-confirmed case of novel pandemic influenza H1N1 2009 in Albania was reported on May 2009. From July to October 2009, Albania experienced a moderate wave of viral transmission; a stronger wave began in November, and a peak in H1N1 incidence occurred during the first week of December 2009. The hospitalization rates were reported every week during the influenza season, which allowed for the collection of information on the number of people with influenza-related complications and total number of such patients admitted into the ICU (Figure 1). The aim of this study was to describe clinical characteristics of ICU admissions, demographic characteristics, and compare treatments to their respective outcomes among critically ill patients with laboratory-confirmed H1N1 virus. Treatment methods include the use of antiviral, and if necessary, antibacterial agents. A matter of debate is which administration mode for the ventilatory support system (oxygen therapy) is more effective. This treatment can be deemed necessary because of the risk of severe lung infection as a result of the H1N1 infection.
The Albanian Ethical Committee approved this observational prospective study. The case-series described the clinical and epidemiologic characteristics of 31 patients with laboratory-confirmed influenza H1N1 infection admitted to the ICU of the Service of Infectious Diseases at the University Hospital Center, Tirana, Albania, during the period November 15, 2009–March 27, 2010. Data were collected and analyzed regarding (1) influenza-like illness (ILI) visits to the emergency department; (2) ILI hospitalizations; (3) confirmed 2009 H1N1 admissions. In all cases, days of stay at the ICU, X-ray thoracic examinations and CT examinations, laboratory serologic findings, and metabolic panels were examined. Blood gases were measured. Each patient’s outcome at discharge was also documented. Nasopharyngeal-swab specimens were collected at admission, and bronchial-aspirate samples were obtained after tracheal intubation. Specimens were tested by RT-PCR at the National Influenza Laboratory (Institute of Public Health), in accordance with the WHO protocol . All study patients had confirmed influenza H1N1 2009 infection.
2.1. Statistical Analysis
Data analysis was conducted using SPSS Statistical Software 18. Days of stay in the ICU and patient outcome at discharge were recorded for each patient. Clinical characteristics were compared between patients who died and those who survived. Cox proportional-hazards regression was used to analyze the effect of several risk factors on survival. The comparison of survival curves for patients requiring endotracheal intubation in the first 24 hours after admission was done using the log-rank test. All reported P values are two-sided and were not adjusted for multiple testing.
3.1. Patients’ Data
Characteristics of the 31 study patients with confirmed 2009 influenza H1N1 infection are listed in Table 1. The ages of the patients ranged from 15 to 78 years (median age: 35 years). Twenty-two patients (71%) were between 15 and 50 years of age, and eight of them (25.8%) were over 50 years of age.
The time between onset of symptoms and admission to the hospital ranged from two to seven days (median, four days), and hospitalization lasted between four days and four weeks (Table 2, Figure 2). All patients had fever with temperatures higher than 38°C, cough with sputum, and dyspnea or respiratory distress. Four (12.9%) patients had emesis and nine (29%) had abdominal pain. None of the patients had diarrhea.
3.2. Underlying Condition
Twelve patients (38.7%) had preexisting medical conditions, and two patients were pregnant. Four patients had arterial hypertension, one patient had diabetes mellitus and hypertension, two patients had chronic respiratory disease, two patients were obese, one patient suffered from congenital heart disorder, one suffered from psychiatric disorders, and one patient previously had a renal transplant. Two of the deceased patients were pregnant, one of the deceased patients had both hypertension and diabetes, and one deceased patient had mitral stenosis (Table 3). None of the patients had undergone seasonal influenza vaccination in 2008-2009, and none of them had a history of pneumococcal vaccination. None of the patients sought medical care at other institutions as outpatients before hospitalization and were not treated with antibiotics.
3.3. Laboratory Findings
Twenty-six patients (83.9%) had pneumonia confirmed with radiological examination. This examination revealed bilateral patchy alveolar opacities (predominantly basal) affecting three or four lung quadrants in 17 patients (Figure 3, Table 2). Findings on chest radiographs were consistent with the acute respiratory distress syndrome in all patients requiring mechanical ventilation.
3.4. Clinical Course during Hospital Stay and ICU Monitoring
Respiratory distress requiring endotracheal intubation developed in five patients within the first 24 hours after admission. Of the five patients that required endotracheal intubation, the four patients that passed away had a median oxygen saturation of 64% in the absence of supplementary oxygen. Noninvasive oxygen therapy (NIV) was used in 15 patients (48.4%) via nasal tube. Continuous positive airway pressure (CPAP) and pressure support ventilation (PSV) oxygen masks were used in 11 patients (35.5%). Altered consciousness was found in nine (29%) patients. The respiratory tract was free of inflammatory obstructions or foreign bodies.
Regarding hemodynamic parameters, arterial hypotension was the predominant symptom. Only four patients presented with arterial pressure values over 150 mmHg. With respect to pulse oximetry, SpO2 ranged from 57 to 93%, while diuresis was generally maintained at a median of 2l/24 h (range 200–2700 mL).
Treatment protocol was followed based on the recommendation of the Centers for Disease Control and Prevention . None of the patients had been treated with oseltamivir before admission; all patients received it in the hospital at a dose of 75 mg twice a day for a minimum of five days. After admission, 19 patients received ceftriaxone and six received clarithromycin. Additional antibiotics were prescribed to several patients on the basis of their clinical course. Additional therapy consisted of the administration of prednisolone (50–100 mg/24 h), oxygen therapy, enteral nutrition, parenteral liquids and electrolytes, vitamins, human albumin, and comorbidity-related medications.
Of the 31 patients, five patients required endotracheal intubation. Four out of the five patients requiring endotracheal intubation died. Overall, out of the 31 patients, 27 patients recovered and were discharged from the hospital. Patients died between one and six days (median, 3.5 days) after admission (Table 1).
The 2009 influenza H1N1 epidemics rapidly spread around the world due to increased travel and communication between countries . The pathology (mostly shown in previously healthy patients) had an influenza-like symptomatology that progressed during a period of four to seven days. Pneumonia and other findings developed during the first day of hospital admission generally fulfilled the criteria of acute lung injury or acute respiratory distress syndrome (ARDS) [9–11]. The development of acute lung injury or ARDS was shown in our patients.
The occurrence of this symptom can lead to patient death. A contributing factor for lethal outcome in our patients may have been due to a delay in seeking medical care and the subsequent delayed admission to a hospital. Albania has also reported a large number of persons with mild disease, through the national surveillance system for influenza with 545 reported cases of AH1N1 infection confirmed from May 2009 to March 2010 (among more than 3000 suspected subjects); of them, 363 were admitted to the University Hospital Center of Tirana [12, 13]. The 31 patients in this study showed relatively severe altered conscience and ventilation, compared to other subjects. Among our patients, four out of five patients (80%) requiring endotracheal intubation did not survive, and the lung damage was most likely due to the primary effect of infection with influenza virus. Other authors have reported similar results [14–16].
In our study, 12 subjects had comorbidities and two patients were pregnant. There was no difference between benign and fatal outcome patients in the association with comorbidities. A history of lung disease, obesity, diabetes, hypertension, psychiatric, and heart disease were the most common comorbidities in our study. Comorbidity presence was a risk factor for severe or atypical disease pattern . Another study reported similar comorbidity rates (36%) with regards to 2009 H1N1 patients in Chile . The relative absence of serious comorbidities in our sample emphasizes that young, relatively healthy adults were the primary population affected by severe 2009 influenza H1N1 infection during this outbreak.
Ventilatory support indication was based upon evaluation of clinical condition of the patients and measurement of arterial blood gases. According to our data, 61% of patients required ventilator support for profound hypoxemic respiratory failure, requiring high levels of inspired oxygen and positive end expiratory pressure (PEEP). The survival rate was higher in NIV than in patients with endotracheal intubation. NIV application rapidly improved vital signs and oxygenation and relieved the patients from tachypnea. Similarly to some reports, none of the patients who received oxygen therapy via nasal sound/mask and NIV required invasive ventilation [18, 19]. Also, evaluation of the fluid status was performed regularly to avoid hypovolemia (hemodynamic instability).
Several studies have shown that noninvasive ventilatory support may decrease mortality obviating the need for endotracheal intubation [16, 19]. In general, patients respond to NIV within 24 hours. Nonresponders who will eventually need endotracheal intubation can thus be identified early. Our findings are consistent with these reports, pointing out that NIV is effective and safe in the context of 2009 influenza H1N1 infection. The complex therapy that includes non-invasive oxygen-support was an effective tool in the management of patients with pandemic influenza H1N1. Moreover, the early administration of oxygen yielded excellent results in the prevention of respiratory complications from the pandemic H1N1 influenza [20, 21]. Our experience with this technique provides strong evidence that NIV can play a role in treating acute respiratory failure patients, reducing the need of ICU beds and improving outcomes.
This is the first study that reported about systematic monitoring of influenza admission at the ICU in Albania. A limitation of this study is the relatively small sample size, and the patient population consists of patients from a single center. Thus, the use of multivariate analysis was not attempted for patients with fatal outcome.
NIV is recommended for patients with H1N1 virus infection complicated by pneumonia, acute lung injury, and ARDS because it improves oxygenation and reduces the work of breathing in these patients, but treatment should also be based upon published, evidence-based guidelines for sepsis-associated ARDS. In fact, standard lung-protective ventilation strategies are appropriate initially [22, 23].
It could be concluded that pandemic H1N1 influenza is associated with severe hypoxemic respiratory failure, often requiring prolonged mechanical ventilation. The reason for the severe hypoxemia observed in these patients and the mode of oxygen therapy application is still of debate. However, NIV could be used based on the results in 2009 influenza H1N1 infection-related hypoxemic respiratory failure by decreasing atelectatic alveoli, improving pulmonary compliance, and reducing work of breathing. Early diagnosis by the consistent symptoms of fever and a respiratory illness during times of outbreak, with prompt treatment of neuraminidase inhibitors and aggressive support of oxygenation failure and subsequent organ dysfunction, may provide better opportunities to mitigate the progression of illness and mortality observed during this severe pathology.
- U.S. Centers for Disease Control and Prevention, “A (H1N1) infection in two children—Southern California,” Morbidity and Mortality Weekly Report, vol. 58, pp. 400–402, March–April 2009.
- U.S. Centers for Disease Control and Prevention, “Update: swine influenza A (H1N1) infections—California and Texas,” Morbidity and Mortality Weekly Report, vol. 58, pp. 435–437, April 2009.
- WHO, Influenza A (H1N1)-update 14. Global Alert and Response (GAR), 2009, http://www.who.int/csr/don/2009_05_04a/en/index.html.
- F. S. Dawood, S. Jain, L. Finelli et al., “Emergence of a novel swine-origin influenza A (H1N1) virus in humans,” The New England Journal of Medicine, vol. 360, no. 25, pp. 2605–2615, 2009.
- U.S. Centers for Disease Control and Prevention, “Update: infections with a swine-origin influenza A (H1N1) virus—United States and other countries,” Morbidity and Mortality Weekly Report, vol. 58, pp. 431–433, April 2009.
- R. A. Fowler, S. E. Lapinsky, D. Hallett et al., “Critically Ill patients with severe acute respiratory syndrome,” Journal of the American Medical Association, vol. 290, no. 3, pp. 367–373, 2003.
- CDC Protocol of Realtime RTPCR for Influenza A (H1N1), World Health Organization, Geneva, Switzerland, 2009.
- M. Canals and A. Canals, “Percolation of influenza AH1N1 epidemic in the world: usefulness of the spatial-connectivity models,” Revista Medica de Chile, vol. 138, no. 5, pp. 573–580, 2010 (Spanish).
- J. F. Murray, M. A. Matthay, J. M. Luce, and M. R. Flick, “An expanded definition of the adult respiratory distress syndrome,” American Review of Respiratory Disease, vol. 138, no. 3, pp. 720–723, 1988.
- D. M. Morens, J. K. Taubenberger, and A. S. Fauci, “Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness,” Journal of Infectious Diseases, vol. 198, no. 7, pp. 962–970, 2008.
- D. J. Mollura, D. S. Asnis, R. S. Crupi et al., “Imaging findings in a fatal case of pandemic swine-origin influenza A (H1N1),” American Journal of Roentgenology, vol. 193, no. 6, pp. 1500–1503, 2009.
- E. Ramosaço, D. Kraja, P. Pipero et al., “Evaluation of the impact of influenza A(H1N1) infection on prengnancy outcome in Albania,” Medicus, vol. 18, no. 2, pp. 33–36, 2012.
- E. Ramosaço, P. Pipero, and E. Kolovani, “Occult form of pandemic A(H1N1) influenza,” Medicus, vol. 19, 2013.
- A. Kumar, R. Zarychanski, R. Pinto et al., “Critically ill patients with 2009 influenza A(H1N1) infection in Canada,” Journal of the American Medical Association, vol. 302, no. 17, pp. 1872–1879, 2009.
- M. Ferrer, A. Esquinas, M. Leon, G. Gonzalez, A. Alarcon, and A. Torres, “Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 12, pp. 1438–1444, 2003.
- M. Confalonieri, G. Garuti, M. S. Cattaruzza et al., “A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation,” European Respiratory Journal, vol. 25, no. 2, pp. 348–355, 2005.
- M. F. Baehr, R. G. Morín, H. J. A. del Solar, R. H. Olivi, and T. J. P. Torres, “Clinical features of adults younger and older than 50 years hospitalized with influenza A H1N1 2009 in a private hospital in Santiago, Chile,” Revista Chilena de Infectologia, vol. 27, no. 2, pp. 139–143, 2010 (Spanish).
- J. L. Vincent, R. Moreno, J. Takala et al., “The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure,” Intensive Care Medicine, vol. 22, no. 7, pp. 707–710, 1996.
- R. Agarwal, C. Reddy, A. N. Aggarwal, and D. Gupta, “Is there a role for noninvasive ventilation in acute respiratory distress syndrome? A meta-analysis,” Respiratory Medicine, vol. 100, no. 12, pp. 2235–2238, 2006.
- G. Domínguez-Cherit, S. E. Lapinsky, A. E. Macias et al., “Critically ill patients with 2009 influenza A(H1N1) in Mexico,” Journal of the American Medical Association, vol. 302, no. 17, pp. 1880–1887, 2009.
- D. S. Hui, S. D. Hall, M. T. V. Chan et al., “Noninvasive positive-pressure ventilation: an experimental model to air and particle dispersion,” Chest, vol. 130, no. 3, pp. 730–740, 2006.
- D. S. Hui, N. Lee, and P. K. S. Chan, “Clinical management of pandemic 2009 influenza A(H1N1) infection,” Chest, vol. 137, no. 4, pp. 916–925, 2010.
- S. A. Ñamendys-Silva, M. Hernández-Garay, and E. Rivero-Sigarroa, “Non-invasive ventilation for critically ill patients with pandemic H1N1 2009 influenza A virus infection,” Critical Care, vol. 14, no. 2, article 407, 2010.
Copyright © 2013 Arben Ndreu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.